Labetuzumab (Anti-CEACAM5 / CEA / CD66e)

製品コード：A2638         Batch: A263801

印刷

Labetuzumab (Anti-CEACAM5 / CEA / CD66e) is a humanised monoclonal antibody targeting carcinoembryonic antigen (CEA). It inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy. MW :145.36 KD.

製品説明

CAS No. 219649-07-7
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Isotype Human IgG1
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions
Purity 99%
Protein concentration 3.25mg/ml
Endotoxin Level ＜1EU/mg

人間や獣医の診断であるか治療的な使用のためにでない。